Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521177 · ClinicalTrials.gov registry record · NA
A Trial to Examine the Efficacy of a Hand Serum and Glove Combination.
A NA study of Skin Health and Skin Care, sponsored by Habelo Beauty.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT06521177: Completed NA study of Skin Health and Skin Care, sponsored by Habelo Beauty.
NCT06521177 is a NA study of Skin Health and Skin Care that has completed, run by Habelo Beauty. The registered enrollment target is 33 participants, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06521177, a NA study of Skin Health and Skin Care, has completed, sponsored by Habelo Beauty.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a virtual, 8-week, interventional crossover trial with 33 female participants aged 35 and older. The study aims to evaluate the efficacy of Habelo Beauty's Activating Hand Serum and Glove combination in improving hand skin health and appearance. During Weeks 1-6, participants will apply the Hand Serum to both hands daily. In Weeks 7-8, they will continue applying the Hand Serum and also wear a glove on one hand. Assessments will be conducted via questionnaires and photos at multiple time points to evaluate primary and secondary endpoints related to skin health parameters.
Primary Outcome
Assessment of overall skin health and hydration parameters, measured through expert skin grading and study-specific questionnaires. These assessments will be conducted at Baseline, Day 1, Week 2, Week 4, Week 6, and Week 8.
Conditions Studied
Interventions
- OTHER Hand Serum and Glove
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-03-21 |
| Est. Completion | 2024-07-07 |
| Phase | NA |
What the finished NCT06521177 record still lists
NCT06521177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 52-participant average among 4 other Skin Health trials with a reported enrollment target (37% lower).
The record links to 3 conditions, with Skin Health appearing as the primary indexed condition, and to 1 intervention - of which Hand Serum and Glove is the first listed.
NCT06521177 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06521177 about?
NCT06521177 is a clinical study titled "A Trial to Examine the Efficacy of a Hand Serum and Glove Combination.". This is a virtual, 8-week, interventional crossover trial with 33 female participants aged 35 and older. The study aims to evaluate the efficacy of Habelo Beauty's Activating Hand Serum and Glove combination in improving hand skin health and appearance. During Weeks 1-6, participants will apply the ...
What is the current status of trial NCT06521177?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-03-21. Estimated completion is 2024-07-07.
What conditions does trial NCT06521177 study?
This clinical trial studies the following conditions: Skin Health, Skin Care, Dermatology.
What interventions are being tested in trial NCT06521177?
The interventions under investigation include: Hand Serum and Glove (OTHER).
Who is sponsoring clinical trial NCT06521177?
This trial is sponsored by Habelo Beauty, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521177 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"
RECRUITING · NA
-
A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area
COMPLETED · NA
-
A Single-Group Clinical Trial to Evaluate the Effects of Health Nag's BioActive Collagen Jelly on Skin, Hair, Nail, and Joint Health
COMPLETED · NA
-
Efficacy of Solarplast for Health and Oxidative Stress
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI